Abstract:In this study, we focus on the influence of higher matrix stiffness on VSMCs senescence and its role in AAA development and get new findings. (1) High matrix promotes VSMCs senescence; (2) High matrix results in disruption of MERC and mitochondria/ER dysfunction in VSMCs; (3) High lipid levels exacerbate the effects of high matrix stiffness, and antilipemic agent CI‐981 reverses these detrimental effects. These processes may enhance our understanding of AAA development and potentially uncover new therapeutic targets for AAA. Abdominal aortic aneurysm (AAA) is a prevalent condition characterized by the weakening and bulging of the abdominal aorta. This study aimed to investigate the impact of a stiff matrix on vascular smooth muscle cells (VSMCs) in AAA development. Bioinformatics analysis revealed that differentially expressed genes (DEGs) in VSMCs of an AAA mouse model were enriched in cellular senescence and related pathways. To simulate aging‐related changes, VSMCs were cultured on stiff matrices, and compared to those on soft matrices, the VSMCs cultured on stiff matrices exhibited cellular senescence. Furthermore, the mutual distance between mitochondria and endoplasmic reticulum (ER) in VSMCs was increased, indicating altered mitochondria–endoplasmic reticulum contacts (MERCs). The observed upregulation of reactive oxygen species (ROS) levels, antioxidant gene expression, and decreased mitochondrial membrane potential suggested the presence of mitochondrial dysfunction in VSMCs cultured on a stiff matrix. Additionally, the induction of ER stress‐related genes indicated ER dysfunction. These findings collectively indicated impaired functionality of both mitochondria and ER in VSMCs cultured on a stiff matrix. Moreover, our data revealed that high lipid levels exacerbated the effects of high matrix stiffness on VSMCs senescence, MERC sites, and mitochondria/ER dysfunction. Importantly, treatment with the antilipemic agent CI‐981 effectively reversed these detrimental effects. These findings provide insights into the role of matrix stiffness, mitochondrial dysfunction, ER stress, and lipid metabolism in AAA development, suggesting potential therapeutic targets for intervention.

Matrix stiffness, endothelial dysfunction and atherosclerosis

Matrix stiffness regulates the interactions between endothelial cells and monocytes.

Matrix stiffness regulates macrophage polarization in atherosclerosis

The influence of microenvironment stiffness on endothelial cell fate: Implication for occurrence and progression of atherosclerosis

The interplay of signaling pathway in endothelial cells-matrix stiffness dependency with targeted-therapeutic drugs

Matrix Stiffening Induces Endothelial Dysfunction Via the TRPV4/microRNA-6740/endothelin-1 Mechanotransduction Pathway

Mirna‐mediated Macrophage Behaviors Responding to Matrix Stiffness and Ox‐ldl

Matrix Stiffness Regulates SMC Functions Via TGF-β Signaling Pathway

Matrix Stiffness-Induced Transcriptome Alterations and Regulatory Mechanisms Revealed by RNA-Seq in Endothelial Cells

Substrate Stiffness Affects Endothelial Cell Junctions and MAPK Signaling Pathway

Effects of shear stress on vascular endothelial functions in atherosclerosis and potential therapeutic approaches

Vascular Extracellular Matrix in Atherosclerosis

Biomechanics-mediated endocytosis in atherosclerosis

Matrix Stiffness Determines the Phenotype of Vascular Smooth Muscle Cell in Vitro and in Vivo: Role of DNA Methyltransferase 1

Mechanical Contribution of Vascular Smooth Muscle Cells in the Tunica Media of Artery

Higher matrix stiffness promotes VSMC senescence by affecting mitochondria–ER contact sites and mitochondria/ER dysfunction

Matrix Stiffness Exacerbates the Proinflammatory Responses of Vascular Smooth Muscle Cell Through the DDR1-DNMT1 Mechanotransduction Axis.

TRPV4 channel contributes to aortic root stiffening and atherosclerotic lesion development

Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy

ENDOTHELIAL MECHANOTRANSDUCTION MECHANISMS FOR VASCULAR PHYSIOLOGY AND ATHEROSCLEROSIS

Vascular Fibrosis in Atherosclerosis